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Abstract 
This paper deals with the development of a microfluidic biochip for the exposure of living cells to nanosecond pulsed electric 
fields (nsPEF). When exposed to ultra short electric pulses (typical duration of 3 to 10 ns), disturbances on the plasma membrane 
and on the intra cellular components occur, modifying the behavioral response of cells exposed to drugs or transgene vectors. 
This phenomenon permits to envision promising therapies. The presented biochip is composed of thick gold electrodes that are 
designed to deliver a maximum of energy to the biological medium containing cells. The temporal and spectral distributions of 
the nsPEF are considered for the design of the chip. In order to validate the fabricated biochip ability to orient the pulse towards 
the cells flowing within the exposition channels, a frequency analysis is provided. High voltage measurements in the time domain 
are performed to characterize the amplitude and the shape of the nsPEF within the exposition channels and compared to 
numerical simulations achieved with a 3D Finite-Difference Time-Domain code. We demonstrate that the biochip is adapted for 
3 ns and 10 ns pulses and that the nsPEF are homogenously applied to the biological cells regardless their position along the 
microfluidic channel. Furthermore, biological tests performed on the developed microfluidic biochip permit to prove its 
capability to permeabilize living cells with nanopulses. To our knowledge, we report here the first successful use of a 
microfluidic device optimized for the achievement and real time observation of the nanoporation of living cells. 
 
Keywords : Nanosecond pulsed electric field (nsPEF), microfluidic, biochip, biological cells, nanoporation 
1. Introduction 
 
The effects of short and intense electric fields on biological cells have been studied for a long time as they are 
known to induce disturbances on the plasma membrane which can become permeable to various molecules (Tsong 
1991). This temporary permeabilization of the plasma membrane allows genes or drugs entering into the cell 
cytosol. This technique is very attractive in various applications such as electrochemotherapy (Marty et al. 2006; 
Mir et al. 2006), cutaneous and subcutaneous tumour nodule treatments (Mir et al. 1998), evaluation of the 
cytotoxicity of nonpermeant or poorly permeant anticancer drugs (Labanauskiene et al. 2007), gene electrotransfer 
to various animal tissues (Andre and Mir 2004; Andre et al. 2008) and latterly with in vivo tests (Gothelf and Gehl 
2010; Heller and Heller 2006). 
More recently, the development of generators allowing to reach very short and high voltage pulses, in the range of 3 
to 10 ns with intensities between 20 to 150 kV/cm, has opened a new important investigation field (Buescher et al. 
2004; Vernier et al. 2004). Different works have reported about the effects on animal cells of these kinds of pulses, 
commonly named nanosecond pulsed electric fields (nsPEF). More precisely, it has been shown that the gene 
electrotransfection efficiency can be improved by nsPEF exposure, also called nanoporation, (Beebe et al. 2003) and 
that disturbances on the cell membrane could be sufficient to render it permeable to small molecules, such as 
propidium iodide (Ibey et al. 2009; Vernier et al. 2006). Beyond their potential effects on the cell membrane, these 
nsPEF show a great interest because they also offer the possibility to disturb the intra cellular structures and 
functions (Beebe and Schoenbach 2005).  
However, the mechanisms implied in the effects of nsPEF on living cells remain still misunderstood. This is mainly 
due to the lack of real-time visualization and monitoring systems during nsPEF application on biological cells. 
Commercial electroporation chambers or cuvettes are commonly used to apply nanosecond pulses on living cells 
(Kenaan et al. 2010; Vernier et al. 2006), but are applied without any possibility to visualize cells in real time during 
the pulse applications which renders difficult the study of their effect.  
In parallel, recent developments of microtechnologies and microfluidics techniques permit consideration of the 
design and fabrication of new innovative tools for biology. The main benefits of these technologies consist in their 
miniaturization and parallelization capabilities, as well as real-time observation in the case where transparent 
materials are used for the device fabrication. In the case of electroporation, miniaturized electrodes permit to expose  
cells on a chip to microsecond duration pulses (typically 100 !s) and intense electric fields (typically 1 kV/cm) 
(Huang and Rubinsky 2001; Krishnaswamy et al. 2007; Le Pioufle et al. 2000; Lee et al. 2009; Wang et al. 2009). 
However, the delivery of the nsPEF (typically 3-10 nanoseconds, 20-45 kV/cm) to the cells without deformation of 
spectral and temporal contents requires a specific design.  
In this context, the work presented in this paper describes the design, fabrication and characterization of a 
miniaturized device specifically optimized for nsPEF exposure of living cells. The proposed device permits the real-
time visualization of the nanoporation of cells, under fluorescent microscopy, thanks to the transparency of exposure 
channels. An electrical characterization of the biochip supported by frequency and time domain measurements and 
simulations is proposed. Biological characterizations of the cells exposed on the chip to 10 ns pulsed electric fields 
using a florescent dye are carried out.  
The development of such microfluidic devices optimized for the real-time visualization of the effect of nsPEF on 
living cells is of prime importance as potentially, their use might provide (a) new knowledge on the nanoporation 
effects (b) high throughput production of  permeabilized cells for further therapeutic uses as drug or gene insertion.     
2. Materials and Methods 
2.1. Design methodology  
 
The biochip is composed of a 50 !m thick SU8 microfluidic channel including thick gold electrodes with a 
typical thickness of 25 !m, in which cells suspended in a biological medium are injected. Gold is chosen as material 
for the electrodes because of its excellent electrical properties and biocompatibility (Dalmay et al. 2010). 
The biochip is designed in such a way that the pulsed electric field is absorbed and dissipated mainly in the 
biological medium placed between the electrodes within which cells to be treated are flowed. To do so, impedance 
matching is necessary between the generator, the transmission line and the nanoporation biochip.  
Considering the frequency spectrum of the applied pulses (typically 0 - 200 MHz), the electrical biochip behavior 
is mainly determined by the properties of the medium flowing within the microfluidic channel. It can be described 
by a parallel CG model, where C and G represent respectively the conductance and the capacitance of the biological 
medium (1).  
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where ! and "r represent respectively the conductivity and the relative permittivity of the biological solution, d 
corresponds to the gap between the electrodes containing the medium, h is the thickness of the microchannel and L 
the length of electrode in contact with the medium into the channel.  
The impedance Ze of this model (2) has to be matched to the impedance of nsPEF generator (Zg = 50 #) in order 
to (a) deliver a maximum of energy to the biological medium, (b) avoid reflections of the nsPEF backwards to the 
generator, (c) avoid temporal distortions of the applied nsPEF.  
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where A = L!h represents the area of the electrical current density. Considering the conductivity ($ = 1 S/m) and the 
relative permittivity ("r = 78) of the used biological media (see section 2.4), a transition frequency appears:  
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Regarding that the impedance has to be matched to Zg = 50 # for most of the spectrum of the applied nsPEF, we 
chose to optimize the impedance mostly from continuous up to this transition frequency tf  where most of the energy 
of the applied nsPEF is concentrated.  
 
We have considered a distance gap (d) between the electrodes set to 150 !m, a height (h) for the SU8 microfluidic 
channels set to 50 !m and a thickness (t) for the electrodes fixed to 25 !m. The chosen value for the thickness of 
gold electrodes (t = 25!m) represents a good compromise between technical constraints and homogeneity of the 
field across the whole microfluidic channel. Then, the length (L) of the electrodes has to be 60 mm. As the biochip 
electrodes are based on a coplanar line model with two parallel microchannels, their length has thus been set to 30 
mm. 
 
 
 
2.2. Fabrication process of the microfluidic biochip 
 
The fabrication process starts with a commercial quartz substrate metalized with a 10nm chromium and a 
150nm gold layer (ACM, France) and is used as the main support for transparent and planar surfaces at the end of 
the process. From this seed layer, electroplating of 25 !m gold electrodes is achieved using an electrolytic bath 
based on potassium aurocyanure (KAu(CN)2). Then a standard UV photolithography using a commercial photoresist 
(S1805, MicroChem) is used to define the electrode shapes. Removal of the excess gold is made on the different 
parts of the device by wet etching with a solution based on Potassium Iodide. Then the Cr seed layer is chemically 
etched. After the removal of the photoresist and the cleaning of the wafer by successive baths of acetone, ethanol 
and water combined with ultrasonic steps, the microfluidic channels are defined by a UV photolithography of a 
transparent commercial photoresist, which allows reaching a high aspect ratio (SU8-2025, MicroChem). The SU8 
layer is 25 !m thick to reach the total thickness of the microfluidic channel set to 50!m. To finish, the biochip is 
packaged using a PDMS (Sylgard® 184 Silicone Elastomer Kit, Dow Corning) membrane. This layer is bonded to 
the SU8 resist using a silanization process based on (3-Aminopropyl)trimethoxysilane (Aldrich) and methanol 
mixture.  
Fig. 1 (a) presents the designed microfluidic biochip with actual measured dimensions and Fig. 2 shows a 
profilometer measurement of the microfluidic biochip. A photograph of the packaged microfluidic biochip is shown 
on Fig. 1 (b). The measured gap between electrodes was d = 130 !m, the thickness obtained for the channel is h = 
47 !m (Fig. 2) and the length of electroplating electrodes is L = 33 mm. Considering the equation (2), the equivalent 
impedance at low frequencies of the two parallel microchannels is 42 #. 
      
Insert Fig.1 
Insert Fig.2 
 
2.3. Electrical Characterization  
 
2.3.1. Numerical modeling 
 
Assuming the parameters given in the previous section, the biochip is realistically modeled. A FDTD code 
(Finite Difference Time Domain) (Leveque et al. 2004; Leveque et al. 1992; Taflove and Hagness 2005; Yee 1966) 
is used to perform the numerical analysis. The analyzed structure is composed of the biochip whose microfluidic 
channels are filled with the biological medium. This FDTD modelling predicts the spatial and temporal evolutions 
of the EM fields within the biochip exposed to nsPEF. 
The biochip structure, Fig. 1 (a), is entirely meshed using classical Yee (Yee 1966) elementary cells of 3D 
parallelepiped shape. In order to model the microfluidic channels as realistically possible, a non-uniform mesh is 
used. A grid resolution ("x, "y and "z) of 200 !m ! 13 !m ! 12 !m is used in the microfluidic channels and 
electrodes area. Otherwise, a large grid step of 200 !m ! 500 !m ! 100 !m is considered. The time resolution is 
equal to 0.026 ps. Each simulation requires 160 000 time iterations taking approximately 5 hours to perform on a 
NEC SX-8 computer cluster.  
In addition to the geometrical dimensions, each elementary cell is defined by the electromagnetic properties, i.e. 
permittivity (#r) and conductivity ($), of the associated material. The considered biological medium properties are #r 
= 78 and $ = 1 S/m. The electrodes are modeled as perfect conductors. For the quartz substrate, the SU8 and the 
PDMS, the permittivity is equal to 3.75, 3.58 and 2.7, respectively. The electromagnetic field is modeled through a 
coaxial cable of 50 ohms impedance and an SMA connector whose outputs are directly soldered on the biochip 
pads. Classical Perfectly Matched Layers (PML) are used to limit the computational domain (Berenger 1996). 
The numerical analysis performed with the FDTD tool provides the electric field distribution in the microfluidic 
channels, the reflection coefficient (S11) and the biochip input impedance. 
 
2.3.2. Experimental setup  
2.3.2.1. Frequency domain 
 
The biochip is experimentally characterized in the frequency domain with its microfluidic channels filled with a 
biological medium. The latter electromagnetic properties are measured at room temperature using a dielectric probe 
(85070E Dielectric probe kit, Agilent, USA) connected to a vector network analyzer (VNA 8753E, HP, USA). The 
measured electrical conductivity and relative permittivity of the biological medium are, at low frequencies, equal to 
1 S/m and 78, respectively. The VNA is also used to measure the biochip reflection coefficient (S11 parameter). The 
impedance is further computed from the reflection coefficient.  
 
2.3.2.2. Time domain 
 
Fig. 3 shows the set-up used for the time domain characterization of the microfluidic biochip exposed to high-
voltage (HV) nsPEF. The exposure set-up is composed of an nsPEF generator, coaxial transmission lines and the 
biochip which allows delivering the pulses to the biological medium.  
Two types of nsPEF are applied and characterized. The first type is provided by a HV generator (FPG 10-1SM10, 
FID Technology, Germany) which allows delivering 10 ns duration pulses with adjustable amplitude up to 10 kV. 
The second type is obtained by HV generator (Horus-Laser HT, France) which can deliver 3 ns duration pulses with 
adjustable amplitude up to 3 kV peak-to-peak (El Amari et al. 2010; Vergne et al. 2008).  
In order to characterize the incident and reflected signals in the exposure set-up, a tap-off (245 NMFFP-100, 
Barth Electronics Technology, USA) is connected between the generator and the biochip using two transmission 
lines (RG 214 cable). The tap-off is a three-port device. The mainline, i.e. nsPEF-biochip line, impedance is 
50 ohms whereas the measurement port, i.e. oscilloscope, impedance is 4950 ohm, allowing the voltage 
measurement with a 1:100 ratio. The electrical delay introduced by the two transmission lines (1 m and 2 m long) 
allows obtaining the incident and reflected waves (Kenaan et al. 2010).  
The applied voltage across the biochip electrodes is measured by a HV probe (2440, Barth Electronic 
Technology, USA). The probe has a large frequency bandwidth (6 GHz) and is designed to have the output 
terminated into a 50 ohm system with a voltage ratio of 1:10. For the measurements, the two conductor pins of the 
probe are placed in direct contact with the input or output of the gold electrodes.  
The measured pulses are displayed on a digital storage oscilloscope (DSO, TDS 6124C, Tektronix, USA). The 
DSO has: 12 GHz frequency bandwidth, 50 ohms input impedance and is limited to 5 V root mean square (RMS) 
voltage intensities. Therefore, 26 dB high voltage attenuators (Model 142, Barth Electronics, USA) are connected 
between the tap-off, the HV probe and the DSO. 
Insert Fig.3 
 
 
2.4. Biological experiments protocol   
 
Biological experiments are carried out with DC-3F cells (Chinese hamster fibroblast lung cells). The cells are 
grown in Minimum Essential Medium (Invitrogen, Cergy-Pontoise, France) supplemented with 10 % fetal bovine 
serum (Invitrogen), 500 U/ml penicillin, 500 µg/ml streptomycin (Invitrogen) defined as complete medium. Cultures 
are maintained in a humidified atmosphere with 5 % CO2 at 37 °C. Cells are routinely passed every two days. 
For the biological experiments, cells are rinsed in PBS (Phosphate Buffered Saline) and harvested by Tryple Express 
(Invitrogen). After centrifugation, the cell pellet is suspended in S-MEM solution (typical concentration of cells 
around 10
6
/ml). 
Cells are injected into the microfluidic channels using a micro syringe pump controller (Micro4
TM
 from World 
Precision Instruments), which is connected to Teflon tubing (internal diameter 0.56 mm) attached to a 1 ml syringe 
(Terumo Medical Corporation). The tubing is then inserted into the inlet of the microfluidic access on top of the 
PDMS cover.    
In order to visualize the effect of nsPEF on living cells, a fluorescent dye named Propidium Iodide (PI) (Sigma-
Aldrich, L’Isle-d’Abeau-Chesne, France) is added to the cell suspension (Bowman et al. 2010). A quantity of 20 !l 
(at 1 mM) is added in 500 !l of the cell suspension. If the plasma membrane is sufficiently disturbed when exposed 
to the nsPEF, the fluorescent dye enters into the cytosol of the cell which becomes fluorescent. Hence, by 
monitoring the fluorescence of exposed cells, one knows if the plasma membrane is affected by the nsPEF. 
A negative control is performed showing that after the injection of cells in the microfluidic channel, no fluorescence 
appears without exposing cells to nsPEF.    
After preparation, the cells are injected in the microfluidic network and exposed to trains of different number of 
pulses (171 or 271 pulses) varying their amplitude (35 or 45 kV/cm). The duration of the applied nsPEF is set to 10 
ns.  
Viability tests are performed in order to confirm that the cells remain functional after exposure to nsPEF. For that 
purpose, two methodologies are followed a) cells are collected after being nanoporated on the biochip and exposed 
to Trypan blue (0.2%), a dye that stains in blue the permeabilized cells (Tennant 1964) b) cells are loaded with a 
fluorescent dye named calcein (through 1 hour incubation with calcein-AM (1!M) at 37°C) to show their 
subsequent permeabilization immediately after the nsPEF delivery, and they are also finally exposed to Trypan blue, 
still in place in the channel, 40 minutes after nsPEF exposure. Both results show a good viability of cells after the 
application of nsPEF. 
 
3. Results and Discussion 
3.1. Electrical behavior  
3.1.1. Frequency domain 
 
Fig. 4 presents the reflection coefficient (S11) and the real part of the impedance Ze obtained by FDTD simulation 
and measurements for the biochip. The simulated and measured results present a very good level of consistency. Fig. 
4 (a) shows that a good impedance matching is obtained for frequencies up to 110 MHz (where |S11| < -10 dB i.e. 
less than 10% of the incident power is reflected). As observed in Fig. 4 (b), for low frequencies, the biochip 
impedance is purely resistive and mainly fixed by the conductivity value of the biological medium. The measured 
and simulated impedance values are around 40 ohms. This value is in accordance with the one obtained with the 
analytical model proposed in section 2.2 considering the dimensions of the fabricated biochip. It can be enhanced by 
adjusting the conductivity value of the biological medium.  
For high frequencies, the dielectric component of the biological solution increases, therefore inducing a decrease of 
the biochip impedance. The impedance matching is thus less effective inducing a deformation in the shape of the 
applied pulses.  
 
 
Insert Fig.4 
 
 
3.1.2. Time domain  
 
 
Two types of nsPEF are applied to the microfluidic biochip: 10 ns duration pulses and 3 ns duration pulses. In Fig. 
4 (c) (d), the voltage measurements, i.e. the generated and applied pulses, are presented. In order to test the limits of 
biochip voltage breakdown, the high voltage intensities are higher than those used in biological experiments. 
10 ns square shape nsPEF measurements 
 
The FID Technology generator delivering 10 ns square shape pulses with a 5.9 kV amplitude is used in the 
experimental set-up. As observed in Fig. 4 (c), the amplitude and duration (10 ns) of the generated and applied 
pulses present a good level of consistency. The rise time is slightly modified by the biochip impedance mismatch for 
high frequencies (good impedance matching is ensured up to about 110 MHz).  
3 ns square shape nsPEF measurements 
 
The Horus-Laser generator delivering 3 ns duration square shape pulses with a 1.77 kV amplitude is used in the 
experimental set-up. As observed in Fig. 4 (d), the amplitude and duration (2.4 ns at half maximum) of the generated 
and applied pulses present a good level of consistency. The amplitude of the applied pulse is slightly lower than the 
generated pulse. This difference can be related to high frequency impedance mismatch of the biochip.  
 
A similar rise time of 1.4 ns is obtained for both the generated and applied pulses. In the previous case (10 ns pulse 
duration), the rise time is shorter (0.5 ns). The fact that the biochip impedance spectrum does not fit to the 
impedance of the generator at high frequencies explains the increase of the rise time duration. 
Spatial-temporal distribution of applied 3 ns and 10 ns pulses  
 
Fig. 5 (spatial and temporal evolution of the electric field within the channel) illustrates the fact that the deformation 
of the nsPEF propagating along the microfluidic channel remains quite acceptable.  
Indeed, as computed with the FDTD tool, the temporal waveform of the pulsed electric field is quite homogeneous 
along the microfluidic channel (z axis), with an amplitude variation between temporal evolution curves that does not 
exceed 4% (case of 10 nS pulses) or 6% (case of 3 nS pulses). This ensures that cells are exposed to the same 
electric field regardless their location into the microfluidic channels. The spatial distribution of the electric field is 
thus quite consistent. 
 
Insert Fig.5 
 
 
3.2 Biological experiments 
Experimental biological tests are performed with 10 ns duration pulses. A train of 171 nsPEF, square shaped, 10 
ns duration is applied with a repetition frequency of 234 Hz. A view (fluorescence or bright field microscopy) of 
cells within the microfluidic channel is recorded before and just after the application of nsPEF.   
 
Insert Fig. 6 
 
As shown on Fig. 6 (a) and (b) (where experimental conditions are set to 171 pulses, amplitude of 45 kV/cm for 
the electric field),  cells fluoresce in red after the application of nsPEF, proving that PI introduces into the cytosol, 
due to the disturbance of the plasma membrane. Note that the observation is made with functional cells located in 
the white circles drawn on this figure (the flashy red spots which can be seen outside of these circles corresponding 
to Propidium Iodide residues from previous experiments. They were not considered for result exploitation). 
Viability of cells submitted to nsPEF treatment was checked thanks to Trypan Blue test, as depicted in material 
and methods section. An average of 98 ± 1% of exposed cells remains still alive 40 minutes after being exposed to 
nsPEF.  
The number of nanopulses that were applied (171 or 271 pulses), as well as the amplitude of the electric field (35 
kV/cm or 45 kV/cm) were tuned in order to confirm the effect of these parameters on the permeabilization ratio 
(different measurements are reported on the table in Fig. 6 (c)). As expected, the number of pulses and their 
amplitude both influence the level of permeabilization. 
These preliminary characterizations of the effect of nanoporation on living cells, in particular on the 
permeabilization of the plasma membrane, were permitted thanks to the real time observation on the miniaturized 
biodevice. Deeper exploitation of this type of device will be conducted together with the development of new nsPEF 
generators (more flexibility in term of pulse duration, amplitude and frequency). Actual results demonstrate the 
capability of the developed microfluidic biochip to address nsPEF to the cells within the microchannel, 
permeabilizing their plasma membrane while keeping a reasonable level of viability. 
 
4. Conclusion 
A new microfluidic biodevice optimized for the nsPEF exposure of living cells has been proposed and 
characterized in this paper. Preliminary results showed the feasibility to use such a device for the study of the 
nanoporation of living cells, as it permits real-time visualization of the effect of nsPEF. Miniaturization of the 
exposure channel allows to investigate more intense field strength by reducing the gap between the electrodes. 
In order to optimize the structure of the biodevice, the amplitude and the shape of the pulses delivered to the 
biological sample were precisely characterized. The matching frequency bandwidth of the microfluidic device 
impedance was measured and can be adjusted with the medium conductivity. The high voltage nsPEF measurements 
associated to the frequency characterization (110 MHz bandwidth) demonstrated the suitability of the developed 
device for 3 ns and 10 ns duration pulses biological experiments.  
Biological tests were performed with the fabricated chip applying an electric field of 45kV/cm to the biological 
cells. They showed that the nanoporation of living cells is effective. The microfluidic biochip ensures real time 
visualization and a good viability of biological samples.  
The development of such biochips for the exposure of cells to nsPEF permits (a) the application of intense and 
short pulsed electric field, (b) the real-time visualization of nsPEF effect on cells, (c) the continuous treatment of 
cells in flux and (d) the conservation of the cell viability without contamination.  
The understanding of biological mechanisms, which can occur during nanoporation of living cells, can be 
achieved by using this type of microfluidic device. To our knowledge, this study reports one of the first successful 
nanoporation of living cells performed and observed in real time on a microfluidic biochip. 
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Figure captions 
 
Fig. 1. (a) Scheme of the designed microfluidic biochip; top and side views and (b) View of the microfabricated microfluidic biochip; full top 
view and zoom on the input microfluidic access.  
 
Fig. 2 (a) Schematic 3D view of fabricated microfluidic biochip (arbitrary scale) and (b) Profilometer scan of the fabricated microfluidic biochip.  
 
Fig. 3. Experimental set-up for high voltage nsPEF application and measurements.  
 
Fig. 4. (a) Reflection coefficient (S11) and (b) real part of the impedance obtained by FDTD simulation and measurements for the biochip; the 
microchannels are filled with the biological medium. Voltage measurements of the generated and applied pulses on the biochip. Two types of 
nsPEF are characterized : (c) 10 ns and (d) 3 ns duration pulses. 
 
Fig. 5. FDTD modelling of the spatial distribution of the voltage across the electrodes along the microfluidic channel. (a) 10 ns pulse, (b) 3 ns 
pulse. Top corner: superposition of curves at x=1 mm (channel inlet) and x=33 mm (channel outlet). 
 
Fig. 6. Photographs of DC-3F cells inside the microfluidic channel of the biochip: (a) before and (b) after exposure to nsPEF (bright field imaging 
and fluorescence imaging - the studied cells are circled) – (c) Table of percentage of permeabilized cells depending both on the number and 
amplitude of applied nsPEF.  
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